Status:
COMPLETED
Study of T-PRED(TM) Compared to Pred Forte(R)
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Study of T-PRED(TM) compared to Pred Forte(R)
Eligibility Criteria
Inclusion
- 18 years of age
Exclusion
- No active or adverse disease
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00699803
Start Date
May 1 2008
End Date
August 1 2008
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618